Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Alpha-1 Antitrypsin-Deficient Macrophages Have Increased Matriptase-Mediated Proteolytic Activity.

Karina Krotova1, George W Marek1, Rejean L Wang1

  • 11 Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, and.

American Journal of Respiratory Cell and Molecular Biology
|April 1, 2017
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Design and initial characterization of a novel mini-promoter for gene therapies targeting the central nervous system.

Molecular therapy. Advances·2026
Same author

Adaptive Regulation of mTOR Activity by AMPK, Akt, and ATF6 Pathways in Pi*Z Alpha-1 Antitrypsin Deficient Hepatocytes.

Biomolecules·2026
Same author

Neutrophil-derived extracellular vesicles in the plasma of alpha-1 antitrypsin deficient individuals reveal pro-inflammatory metabolic and transcriptomic signatures.

Extracellular vesicle·2026
Same author

Alpha-defensins promote macrophage inflammatory activation via RNF31 signaling.

Genes & genomics·2026
Same author

Protein Aggregates in Heterozygous Alpha-1 Antitrypsin Phenotype Is a Marker for Progressive Disease.

Gastro hep advances·2025
Same author

Pioglitazone reduces hepatic α-1 antitrypsin accumulation through autophagy and AMPK activation in α-1 antitrypsin-deficient mice.

American journal of physiology. Gastrointestinal and liver physiology·2025

Alpha-1 antitrypsin deficiency causes emphysema. Mutated Z-AAT in macrophages impairs their function, increasing lung tissue breakdown. This macrophage dysfunction contributes to emphysema progression.

Area of Science:

  • Pulmonary Medicine
  • Cell Biology
  • Biochemistry

Background:

  • Alpha-1 antitrypsin (AAT) deficiency is linked to emphysema, primarily due to neutrophil elastase.
  • Current augmentation therapy only slows disease progression, suggesting other factors contribute to lung destruction.

Purpose of the Study:

  • To investigate the role of alveolar macrophages (Mɸ) expressing mutated Z-AAT in emphysema pathogenesis.
  • To determine if intracellular Z-AAT accumulation in Mɸ compromises their function and promotes extracellular matrix (ECM) degradation.

Main Methods:

  • Compared ECM proteolytic activity of Mɸ from Z-AAT individuals (Z-Mɸ) with normal Mɸ.
  • Utilized pharmacologic inhibitors to identify proteases involved in Z-Mɸ ECM degradation.
  • Assessed the expression of matriptase and its role in Z-Mɸ proteolytic activity and MMP-14 regulation.
Keywords:
alpha-1 antitrypsin deficiencyextracellular matrix degradationmacrophagesmatriptasematrix metalloproteinase-14

Related Experiment Videos

Main Results:

  • Z-Mɸ exhibit enhanced proteolytic activity on ECM compared to normal Mɸ, independent of exogenous AAT.
  • Intracellular Z-AAT accumulation in Mɸ leads to cellular dysfunction and increased ECM degradation.
  • Matriptase levels are elevated in Z-Mɸ and contribute to ECM degradation, partly via MMP-14 activation.

Conclusions:

  • Z-AAT expression in Mɸ increases their proteolytic activity on ECM.
  • This Mɸ-driven ECM degradation is resistant to exogenous AAT and may contribute to treatment resistance in emphysema.